Left Atrial Phasic Function via Cardiac Magnetic Resonance Imaging in Patients with Duchenne Muscular Dystrophy

Taylor M Trussell1,2,3, Tyler Brown4,5,6, Elisa Marcuccio4,5,6

  • 1Heart Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 45229, USA. Taylor.Trussell@cchmc.org.

Pediatric Cardiology
|November 8, 2023
PubMed

Insights

Left atrial (LA) function is impaired in Duchenne muscular dystrophy (DMD) patients, with reduced emptying fraction correlating with age and worsening cardiac function. Strain markers indicate early LA compliance and relaxation issues in DMD cardiomyopathy.

Area of Science:

  • Cardiology
  • Medical Imaging
  • Genetics

Background:

  • Duchenne muscular dystrophy (DMD) is a leading cause of cardiac morbidity and mortality.
  • Left atrial (LA) function in DMD is not well understood, despite potential structural changes.
  • Cardiac magnetic resonance (CMR) imaging offers a non-invasive method to assess LA function.

Purpose of the Study:

  • To evaluate and compare left atrial (LA) phasic function in Duchenne muscular dystrophy (DMD) patients using cardiac magnetic resonance (CMR) imaging.
  • To investigate the relationship between LA function, patient age, and left ventricular (LV) systolic function in DMD.
  • To identify early indicators of cardiac dysfunction in DMD using LA strain parameters.

Main Methods:

  • Retrospective review of 107 DMD and 79 normal CMR studies.
  • Analysis of LA strain measurements (reservoir, conduit, boost-pump) and LA volumes.
  • Spearman correlation analyses to assess relationships between variables.

Main Results:

  • DMD cohort showed worse systolic function, smaller LA/LV volumes, and greater LA emptying fraction compared to controls.
  • In DMD patients, LA emptying fraction decreased with age and declining systolic function.
  • Moderate/severe LV dysfunction in DMD was linked to lower LA emptying fraction and impaired LA reservoir, pump, and conduit strain.

Conclusions:

  • DMD patients with preserved function have smaller LA volumes and higher LA emptying fractions than controls.
  • Disease progression and age are associated with decreased LA emptying fraction and early impairment in reservoir and conduit strain.
  • LA strain markers reflect LA compliance and early LV relaxation, indicating worsening cardiomyopathy in DMD.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
15
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
22
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
11